Davis Polk advised the representatives of the several underwriters on the offering. Elevance Health (f/k/a Anthem, Inc.) announced its offering of $1.8 billion in aggregate principal...
You must be a Standard 1 Year member to access this content.
Davis Polk advised European Biotech Acquisition Corp. on the deal while Cooley and Vischer represented Oculis. European Biotech Acquisition Corp. (EBAC), a SPAC, signed its $200 million...
You must be a Standard 1 Year member to access this content.
Davis Polk advised Immatics on the offering while Covington represented underwriters. Immatics N.V. executed its $110 million SEC-registered offering of ordinary shares. The ordinary shares are...
You must be a Standard 1 Year member to access this content.
Greenberg Traurig advised SL Green on the deal, while Davis Polk advised affiliates of RXR Realty. SL Realty Corp., New York City’s largest owner of office...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the sales agents in the offering. Core Laboratories N.V. (Core Lab) announced its at-the-market offering program under which Core Lab may from time to...
You must be a Standard 1 Year member to access this content.
Cravath represented Qualcomm, while Davis Polk advised the representatives of the several underwriters in the offering. Qualcomm Incorporated executed its offering of $500 million aggregate principal...
You must be a Standard 1 Year member to access this content.
Davis Polk advised Livent Corporation on the deal. Livent Corporation announced the investment in Nemaska Lithium Inc. to double Livent’s ownership interest to 50% of Nemaska...
You must be a Standard 1 Year member to access this content.
Davis Polk advised TorQuest Partners in the deal. TorQuest Partners Fund IV and other shareholders sold their interests in Can Art Aluminum Extrusion, a portfolio company...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the sales agents in the transaction. The transaction consists in a new SEC-registered at-the-market offering program by Denali Therapeutics Inc. under which Denali...
You must be a Standard 1 Year member to access this content.
White & Case has advised Screaming Eagle Acquisition Corp. on the deal, while Davis Polk advised the representatives of the underwriters. Screaming Eagle Acquisition Corp., a...
You must be a Standard 1 Year member to access this content.
Davis Polk advised Goldman Sachs & Co. as representative of the initial purchasers in the offering. The Dun & Bradstreet Corporation executed its offering of $460...
You must be a Standard 1 Year member to access this content.
Willkie Farr & Gallagher advised Victory Capital Holdings, while Davis Polk advised the representatives of the several underwriters in the offering. Victory Capital Holdings, Inc. announced the...
You must be a Standard 1 Year member to access this content.
